Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Panacea Life Sciences Holdings Inc (PK) (PLSH)
Panacea Life Sciences Holdings Inc (PK) (PLSH) Actualités

PLSH

Panacea Life Sciences (PK) (PLSH)

Panacea Life Sciences Holdings Inc (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:PLSH

1

Date	Heure	Source	Titre	Symbole	Société
11/06/2024	23h12	Edgar (US Regulatory)	Form 1-A - Offering Statement [Regulation A]	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
16/05/2024	14h37	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
06/05/2024	15h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
08/12/2023	21h04	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
20/09/2023	18h21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
15/08/2023	17h19	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
18/07/2023	18h41	InvestorsHub NewsWire	Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
23/06/2023	23h11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
12/06/2023	22h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
02/06/2023	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
30/03/2023	22h08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
30/01/2023	12h11	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
15/08/2022	13h11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
27/06/2022	22h06	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
05/04/2022	18h00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
20/12/2021	15h17	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
17/12/2021	22h26	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
09/12/2021	17h21	InvestorsHub NewsWire	Panacea Life Sciences, Inc. establishes a presence in Brazil as early as January 2022	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)

Showing the most relevant articles for your search:USOTC:PLSH

1

Cie de SaintGobain

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales